Konkal-Matt R Prasad

Title: Konkal-Matt R Prasad: Innovator in Gene Therapy

Introduction

Konkal-Matt R Prasad is a notable inventor based in Charlottesville, VA (US). He has made significant contributions to the field of gene therapy, particularly in the protection of pancreatic β-cells from immune system-mediated damage. His innovative approach has the potential to impact the treatment of Type 1 diabetes.

Latest Patents

Konkal-Matt R Prasad holds 1 patent for his invention titled "Use of adeno-associated virus (AAV) to deliver genes." This invention focuses on a method that protects pancreatic β-cells from immune system-mediated cell damage through the transduction of these cells with an adeno-associated viral vector encoding cytoprotective genes. The protected cells are suitable for transplantation into mammals and are safeguarded from rejection by the host. Additionally, this method may be utilized to protect pancreatic islet β-cells in situ, serving as a primary prevention strategy against immune-mediated destruction leading to Type 1 diabetes. The invention allows for the transduction of pancreatic β-cells with AAV vectors for both in vivo and ex vivo gene therapy.

Career Highlights

Konkal-Matt R Prasad is associated with City of Hope, where he continues to advance his research and innovations in gene therapy. His work is pivotal in developing new therapeutic strategies for diabetes and other related conditions.

Collaborations

He collaborates with esteemed colleagues such as Jerry L Nadler and David Bleich, contributing to a rich environment of research and innovation.

Conclusion

Konkal-Matt R Prasad's contributions to gene therapy exemplify the potential of innovative approaches in medicine. His work not only enhances our understanding of pancreatic β-cell protection but also paves the way for future advancements in diabetes treatment.